Biden administration doles out $100M to research drug-resistant infections

Lia DeGroot

The Biden administration is pumping $100 million into a research project focused on combating the threat of drug-resistant bacteria, the Advanced Research Projects Agency for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Biden administration doles out $100M to research drug-resistant infections

Lia DeGroot

Sign up to read this article for free.

First meeting of CDC vaccine advisors in the Kennedy era is postponed

In single case, spinal muscular atrophy drug given before birth spared baby of genetic disease symptoms

How Keymed steered the China-to-US NewCo model in biotech

BridgeBio’s heart disease drug Attruby sails past prescription estimates

Drug packaging manufacturers brace for impact as EU chemical ban looms

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Biden ad­min­is­tra­tion doles out $100M to re­search drug-re­sis­tant in­fec­tions

Lia DeGroot

Sign up to read this article for free.

First meet­ing of CDC vac­cine ad­vi­sors in the Kennedy era is post­poned

In sin­gle case, spinal mus­cu­lar at­ro­phy drug giv­en be­fore birth spared ba­by of ge­net­ic dis­ease symp­toms

How Keymed steered the Chi­na-to-US New­Co mod­el in biotech

Bridge­Bio’s heart dis­ease drug At­tru­by sails past pre­scrip­tion es­ti­mates

Drug pack­ag­ing man­u­fac­tur­ers brace for im­pact as EU chem­i­cal ban looms

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

Biden administration doles out $100M to research drug-resistant infections

First meeting of CDC vaccine advisors in the Kennedy era is postponed

In single case, spinal muscular atrophy drug given before birth spared baby of genetic disease symptoms

How Keymed steered the China-to-US NewCo model in biotech

BridgeBio’s heart disease drug Attruby sails past prescription estimates

Drug packaging manufacturers brace for impact as EU chemical ban looms

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence